Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health Services Inc. has demonstrated a strong performance in its OP Rehab segment, achieving growth in the double digits and generating attractive margins. The Pharmacy Solutions segment saw significant revenue growth in 2025, with specialty revenue reaching approximately $2.6 billion, reflecting a 43% year-over-year increase and an improving EBITDA margin. Furthermore, the Provider Services division has benefited from strategic acquisitions, showcasing stability and growth in home health and other services, while also positioning BrightSpring to capitalize on the expanding specialty drug market and continued cost savings in healthcare.

Bears say

BrightSpring Health Services Inc. faces a negative outlook primarily due to potential client budget constraints, which could significantly impact its revenue and operational stability. Additionally, a heavy debt load may restrict the company’s ability to invest in growth opportunities, further complicating its financial trajectory. Furthermore, reduced prescription writing by healthcare professionals and decreased drug utilization pose substantial risks that could adversely affect the company's cash flows and operating results.

BTSG has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 9 analysts, BTSG has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $47.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $47.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.